323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

Alimera Sciences Initiated at Buy by Maxim Group

Alimera Sciences Initiated at Buy by Maxim Group

Dow JonesMar 25 20:14

Maxim Group Initiates Coverage On Alimera Sciences With Buy Rating, Announces Price Target of $10

Maxim Group analyst Naz Rahman initiates coverage on Alimera Sciences with a Buy rating and announces Price Target of $10.

Analyst UpgradesMar 25 20:03

The Top Stocks With Buying Pressure Across the Russell Universe - Jefferies

Seeking AlphaMar 20 23:40

Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, March 20, 2024 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) ("Alimera" or the "Company"), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners

GlobeNewswireMar 20 20:00

Alimera Announces First Patient Randomized In Radiation Retinopathy Trial Being Conducted By The DRCR Retina Network

Alimera Announces First Patient Randomized In Radiation Retinopathy Trial Being Conducted By The DRCR Retina Network

BenzingaMar 19 20:05